Difference between revisions of "Synthetic Biology Patent Application Trends 2024"

From WikiPatents
Jump to navigation Jump to search
(Updating Synthetic Biology Patent Application Trends 2024)
 
(Updating Synthetic Biology Patent Application Trends 2024)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
== Synthetic Biology Patent Application Filing Activity ==
 
== Synthetic Biology Patent Application Filing Activity ==
 
== Synthetic Biology patent applications in 2024 ==
 
== Synthetic Biology patent applications in 2024 ==
−
[[File:Synthetic_Biology_Monthly_Patent_Applications_2024_-_Up_to_June 2024.png|border|800px]]
+
[[File:Synthetic_Biology_Monthly_Patent_Applications_2024_-_Up_to_November 2024.png|border|800px]]
  
 
== Top Technology Areas in Synthetic Biology ==
 
== Top Technology Areas in Synthetic Biology ==
−
[[File:Top_Technology_Areas_in_Synthetic_Biology_2024_-_Up_to_June 2024.png|border|800px]]
+
[[File:Top_Technology_Areas_in_Synthetic_Biology_2024_-_Up_to_November 2024.png|border|800px]]
  
 
=== Top CPC Codes ===
 
=== Top CPC Codes ===
−
* [[:Category:CPC_C12P19/12|C12P19/12]] (No explanation available)
+
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
−
** Count: 4 patents
+
** Count: 102 patents
−
** Example: [[20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]]
−
* [[:Category:CPC_C12N9/1085|C12N9/1085]] (No explanation available)
 
−
** Count: 3 patents
 
−
** Example: [[20240101614. CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS simplified abstract (Inscripta, Inc.)]]
 
 
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
 
* [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available)
−
** Count: 3 patents
+
** Count: 96 patents
−
** Example: [[20240101989. NUCLEASE-MEDIATED GENOME EDITING simplified abstract (Wageningen Universiteit)]]
+
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
−
* [[:Category:CPC_C12N1/205|C12N1/205]] (No explanation available)
+
* [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available)
−
** Count: 3 patents
+
** Count: 46 patents
−
** Example: [[20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]]
−
* [[:Category:CPC_C12N9/1081|C12N9/1081]] (No explanation available)
+
* [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available)
−
** Count: 3 patents
+
** Count: 34 patents
−
** Example: [[20240200021. CELLULAR PRODUCTION OF SIALYLATED DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]]
−
* [[:Category:CPC_C12N9/1051|C12N9/1051]] (No explanation available)
+
* [[:Category:CPC_C12N15/102|C12N15/102]] (No explanation available)
−
** Count: 3 patents
+
** Count: 27 patents
−
** Example: [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
 +
* [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available)
 +
** Count: 27 patents
 +
** Example: [[20240229024. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]]
 +
* [[:Category:CPC_C12N2800/80|C12N2800/80]] (No explanation available)
 +
** Count: 27 patents
 +
** Example: [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]]
 
* [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available)
 
* [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available)
−
** Count: 2 patents
+
** Count: 18 patents
−
** Example: [[20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF simplified abstract (Massachusetts Institute of Technology)]]
+
** Example: [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]]
−
* [[:Category:CPC_C12N2310/14|C12N2310/14]] (No explanation available)
+
* [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available)
−
** Count: 2 patents
+
** Count: 17 patents
−
** Example: [[20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF simplified abstract (Massachusetts Institute of Technology)]]
+
** Example: [[20240350666. COMPOSITIONS AND METHODS FOR HIGH EFFICIENCY GENOME EDITING (Children`s Medical Center Corporation)]]
−
* [[:Category:CPC_C07K14/415|C07K14/415]] (No explanation available)
+
* [[:Category:CPC_C12N15/63|C12N15/63]] (No explanation available)
−
** Count: 2 patents
+
** Count: 14 patents
−
** Example: [[20240101614. CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS simplified abstract (Inscripta, Inc.)]]
+
** Example: [[20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF (Massachusetts Institute of Technology)]]
−
* [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available)
 
−
** Count: 2 patents
 
−
** Example: [[20240101989. NUCLEASE-MEDIATED GENOME EDITING simplified abstract (Wageningen Universiteit)]]
 
  
 
== Top Companies in Synthetic Biology ==
 
== Top Companies in Synthetic Biology ==
Line 42: Line 42:
  
 
=== [[:Category:INBIOSE N.V.|INBIOSE N.V.]] ===
 
=== [[:Category:INBIOSE N.V.|INBIOSE N.V.]] ===
−
* Number of Synthetic Biology patents: 5
+
* Number of Synthetic Biology patents: 9
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12P19/12|C12P19/12]] (No explanation available): 4 patents
+
** [[:Category:CPC_C12N9/1081|C12N9/1081]] (No explanation available): 5 patents
−
** [[:Category:CPC_C12N1/205|C12N1/205]] (No explanation available): 3 patents
+
** [[:Category:CPC_C12P19/12|C12P19/12]] (No explanation available): 5 patents
−
** [[:Category:CPC_C12N9/1081|C12N9/1081]] (No explanation available): 3 patents
+
** [[:Category:CPC_C12N9/1051|C12N9/1051]] (No explanation available): 5 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES simplified abstract (INBIOSE N.V.)]] (20240201)
+
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
−
** [[20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.)]] (20240613)
+
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
−
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)]] (20240314)
+
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
−
=== [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]] ===
+
=== [[:Category:The General Hospital Corporation|The General Hospital Corporation]] ===
−
* Number of Synthetic Biology patents: 2
+
* Number of Synthetic Biology patents: 7
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available): 1 patents
+
** [[:Category:CPC_C07K16/18|C07K16/18]] (No explanation available): 2 patents
−
** [[:Category:CPC_A61K48/0066|A61K48/0066]] (No explanation available): 1 patents
+
** [[:Category:CPC_A61P25/28|A61P25/28]] (No explanation available): 2 patents
−
** [[:Category:CPC_C12N15/63|C12N15/63]] (No explanation available): 1 patents
+
** [[:Category:CPC_C07K14/775|C07K14/775]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240124877. RNA CLEAVAGE-INDUCED TRANSCRIPT STABILIZER AND USES THEREOF simplified abstract (Massachusetts Institute of Technology)]] (20240418)
+
** [[20240240207. Increasing Specificity for RNA-Guided Genome Editing (The General Hospital Corporation)]] (20240718)
−
** [[20240067957. AUTOCATALYTIC BASE EDITING FOR RNA-RESPONSIVE TRANSLATIONAL CONTROL simplified abstract (Massachusetts Institute of Technology)]] (20240229)
+
** [[20240066102. Genome editing approaches to treat Spinal Muscular Atrophy (The General Hospital Corporation)]] (20240229)
−
=== [[:Category:Inscripta, Inc.|Inscripta, Inc.]] ===
+
** [[20240218334. Biosensors in Human Gut Organoids (The General Hospital Corporation)]] (20240704)
−
* Number of Synthetic Biology patents: 1
+
=== [[:Category:Fate Therapeutics, Inc.|Fate Therapeutics, Inc.]] ===
 +
* Number of Synthetic Biology patents: 6
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C07K14/415|C07K14/415]] (No explanation available): 1 patents
+
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 5 patents
−
** [[:Category:CPC_C12N9/1085|C12N9/1085]] (No explanation available): 1 patents
+
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 4 patents
 +
** [[:Category:CPC_A61P35/00|A61P35/00]] (No explanation available): 4 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240101614. CHAPERONES FOR HETEROLOGOUS EXPRESSION SYSTEMS simplified abstract (Inscripta, Inc.)]] (20240328)
+
** [[20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES (Fate Therapeutics, Inc.)]] (20240919)
−
=== [[:Category:Wageningen Universiteit|Wageningen Universiteit]] ===
+
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
−
* Number of Synthetic Biology patents: 1
+
** [[20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS (Fate Therapeutics, Inc.)]] (20240201)
 +
=== [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]] ===
 +
* Number of Synthetic Biology patents: 4
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 4 patents
−
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
−
** [[:Category:CPC_C07K2319/09|C07K2319/09]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240101989. NUCLEASE-MEDIATED GENOME EDITING simplified abstract (Wageningen Universiteit)]] (20240328)
+
** [[20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240711)
−
=== [[:Category:Jiangnan University|Jiangnan University]] ===
+
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
−
* Number of Synthetic Biology patents: 1
+
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
 +
=== [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]] ===
 +
* Number of Synthetic Biology patents: 4
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12P7/02|C12P7/02]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N15/111|C12N15/111]] (No explanation available): 4 patents
−
** [[:Category:CPC_C12N9/1085|C12N9/1085]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 3 patents
−
** [[:Category:CPC_C12N9/88|C12N9/88]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/1276|C12N9/1276]] (No explanation available): 3 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240117387. P450 Cytochrome Enzyme for Andrographolide Synthesis and Its Application simplified abstract (Jiangnan University)]] (20240411)
+
** [[20240117382. DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) (The Broad Institute, Inc.)]] (20240411)
−
=== [[:Category:ETH ZÜRICH|ETH ZÜRICH]] ===
+
** [[20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE (The Broad Institute, Inc.)]] (20240516)
−
* Number of Synthetic Biology patents: 1
+
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
 +
=== [[:Category:Massachusetts Institute of Technology|Massachusetts Institute of Technology]] ===
 +
* Number of Synthetic Biology patents: 4
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12N15/113|C12N15/113]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
−
** [[:Category:CPC_C12N15/86|C12N15/86]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 2 patents
−
** [[:Category:CPC_C12N2310/14|C12N2310/14]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N15/11|C12N15/11]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240209357. DNA CONSTRUCTS COMPRISING ALTERNATIVE PROMOTERS simplified abstract (ETH ZÜRICH)]] (20240627)
+
** [[20240301373. FANZORS ARE RNA-GUIDED NUCLEASES ENCODED IN EUKARYOTIC GENOMES (Massachusetts Institute of Technology)]] (20240912)
−
=== [[:Category:THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY|THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY]] ===
+
** [[20240067957. AUTOCATALYTIC BASE EDITING FOR RNA-RESPONSIVE TRANSLATIONAL CONTROL (Massachusetts Institute of Technology)]] (20240229)
−
* Number of Synthetic Biology patents: 1
+
** [[20240035008. GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS (Massachusetts Institute of Technology)]] (20240201)
 +
=== [[:Category:The Board of Trustees of the Leland Stanford Junior University|The Board of Trustees of the Leland Stanford Junior University]] ===
 +
* Number of Synthetic Biology patents: 4
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12M41/00|C12M41/00]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 4 patents
−
** [[:Category:CPC_C12M27/16|C12M27/16]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
 +
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240052285. IMAGING-ENABLED BIOREACTOR FOR IN VITRO CULTIVATION AND BIOENGINEERING OF ISOLATED AIRWAY TISSUE simplified abstract (THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY)]] (20240215)
+
** [[20240263173. HIGH-THROUGHPUT PRECISION GENOME EDITING IN HUMAN CELLS (The Board of Trustees of the Leland Stanford Junior University)]] (20240808)
−
=== [[:Category:COLORADO STATE UNIVERSITY RESEARCH FOUNDATION|COLORADO STATE UNIVERSITY RESEARCH FOUNDATION]] ===
+
** [[20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction (The Board of Trustees of the Leland Stanford Junior University)]] (20241205)
−
* Number of Synthetic Biology patents: 1
+
** [[20240018493. KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION (The Board of Trustees of the Leland Stanford Junior University)]] (20240118)
 +
=== [[:Category:UNIVERSITY OF MASSACHUSETTS|UNIVERSITY OF MASSACHUSETTS]] ===
 +
* Number of Synthetic Biology patents: 4
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12N15/8259|C12N15/8259]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
−
** [[:Category:CPC_C02F3/327|C02F3/327]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 3 patents
−
** [[:Category:CPC_C07K14/415|C07K14/415]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N15/907|C12N15/907]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240060080. SYNTHETIC DESALINATION GENETIC CIRCUIT IN PLANTS simplified abstract (COLORADO STATE UNIVERSITY RESEARCH FOUNDATION)]] (20240222)
+
** [[20240141359. GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY (UNIVERSITY OF MASSACHUSETTS)]] (20240502)
−
=== [[:Category:Duke University|Duke University]] ===
+
** [[20240167029. MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING (UNIVERSITY OF MASSACHUSETTS)]] (20240523)
−
* Number of Synthetic Biology patents: 1
+
** [[20240036027. Nanopore Biosensors and Uses Thereof (UNIVERSITY OF MASSACHUSETTS)]] (20240201)
 +
=== [[:Category:Wisconsin Alumni Research Foundation|Wisconsin Alumni Research Foundation]] ===
 +
* Number of Synthetic Biology patents: 3
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12P7/42|C12P7/42]] (No explanation available): 1 patents
+
** [[:Category:CPC_A61K35/17|A61K35/17]] (No explanation available): 2 patents
−
** [[:Category:CPC_C12N9/0006|C12N9/0006]] (No explanation available): 1 patents
+
** [[:Category:CPC_A61K39/4611|A61K39/4611]] (No explanation available): 2 patents
−
** [[:Category:CPC_C12N9/0008|C12N9/0008]] (No explanation available): 1 patents
+
** [[:Category:CPC_A61K39/4631|A61K39/4631]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240035052. COMPOSITIONS AND METHODS FOR METABOLIC CONTROL OF A BIOFERMENTATION PROCESS WITH SYNTHETIC METABOLIC VALVES simplified abstract (Duke University)]] (20240201)
+
** [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240711)
−
=== [[:Category:Eligo Biosciecne|Eligo Biosciecne]] ===
+
** [[20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240425)
−
* Number of Synthetic Biology patents: 1
+
** [[20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME (Wisconsin Alumni Research Foundation)]] (20240125)
 +
=== [[:Category:Prime Medicine, Inc.|Prime Medicine, Inc.]] ===
 +
* Number of Synthetic Biology patents: 3
 
* Top CPC codes:
 
* Top CPC codes:
−
** [[:Category:CPC_C12N7/00|C12N7/00]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 3 patents
−
** [[:Category:CPC_C12N9/22|C12N9/22]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N9/1276|C12N9/1276]] (No explanation available): 2 patents
−
** [[:Category:CPC_C12N15/102|C12N15/102]] (No explanation available): 1 patents
+
** [[:Category:CPC_C12N2310/20|C12N2310/20]] (No explanation available): 2 patents
 
* Recent patents:
 
* Recent patents:
−
** [[20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)]] (20240704)
+
** [[20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY (Prime Medicine, Inc.)]] (20241024)
 +
** [[20240376466. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FANCONI ANEMIA (Prime Medicine, Inc.)]] (20241114)
 +
** [[20240360476. Genome Editing Compositions and Methods for Treatment of Myotonic Dystrophy (Prime Medicine, Inc.)]] (20241031)
  
 
== New Companies in Synthetic Biology (Last Month) ==
 
== New Companies in Synthetic Biology (Last Month) ==
Line 131: Line 150:
 
[[File:Emerging_Technology_Areas_in_Synthetic_Biology.png|border|800px]]
 
[[File:Emerging_Technology_Areas_in_Synthetic_Biology.png|border|800px]]
  
−
* [[:Category:CPC_C12N15/902|C12N15/902]] (No explanation available)
+
* [[:Category:CPC_G01N27/44704|G01N27/44704]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation)]]
+
** Example: [[20240044837. BIOSENSOR (Taiwan Semiconductor Manufacturing Company, Ltd.)]]
−
* [[:Category:CPC_C12Q1/6897|C12Q1/6897]] (No explanation available)
+
* [[:Category:CPC_B03C5/005|B03C5/005]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation)]]
+
** Example: [[20240044837. BIOSENSOR (Taiwan Semiconductor Manufacturing Company, Ltd.)]]
−
* [[:Category:CPC_C12Q1/689|C12Q1/689]] (No explanation available)
+
* [[:Category:CPC_G01N27/44782|G01N27/44782]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation)]]
+
** Example: [[20240044837. BIOSENSOR (Taiwan Semiconductor Manufacturing Company, Ltd.)]]
−
* [[:Category:CPC_C12N15/87|C12N15/87]] (No explanation available)
+
* [[:Category:CPC_A61P25/00|A61P25/00]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)]]
+
** Example: [[20240043830. MULTIPLEX EPIGENOME EDITING (The Trustees of Columbia University in the City of New York)]]
−
* [[:Category:CPC_C12N15/102|C12N15/102]] (No explanation available)
+
* [[:Category:CPC_G16B50/30|G16B50/30]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)]]
+
** Example: [[20240320462. Biocomputing platform and Boolean logic gates (Regents of the University of Minnesota)]]
−
* [[:Category:CPC_C12N7/00|C12N7/00]] (No explanation available)
+
* [[:Category:CPC_G06N3/002|G06N3/002]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240218335. TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS simplified abstract (Eligo Biosciecne)]]
+
** Example: [[20240320462. Biocomputing platform and Boolean logic gates (Regents of the University of Minnesota)]]
−
* [[:Category:CPC_C12Y206/01016|C12Y206/01016]] (No explanation available)
+
* [[:Category:CPC_G01N33/02|G01N33/02]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240319126. MULTI-SCALE, NANO- TO MESOSTRUCTURAL ENGINEERING OF SILK BIOPOLYMER-INTERLAYER BIOSENSORS FOR CONTINUOUS CO-MONITORING OF NUTRIENTS IN FOOD (The Regents of the University of California)]]
−
* [[:Category:CPC_C12Y204/99003|C12Y204/99003]] (No explanation available)
+
* [[:Category:CPC_G01N27/227|G01N27/227]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240319126. MULTI-SCALE, NANO- TO MESOSTRUCTURAL ENGINEERING OF SILK BIOPOLYMER-INTERLAYER BIOSENSORS FOR CONTINUOUS CO-MONITORING OF NUTRIENTS IN FOOD (The Regents of the University of California)]]
−
* [[:Category:CPC_C12Y204/01222|C12Y204/01222]] (No explanation available)
+
* [[:Category:CPC_G01N27/221|G01N27/221]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240319126. MULTI-SCALE, NANO- TO MESOSTRUCTURAL ENGINEERING OF SILK BIOPOLYMER-INTERLAYER BIOSENSORS FOR CONTINUOUS CO-MONITORING OF NUTRIENTS IN FOOD (The Regents of the University of California)]]
−
* [[:Category:CPC_C12N9/1096|C12N9/1096]] (No explanation available)
+
* [[:Category:CPC_C12Y303/01001|C12Y303/01001]] (No explanation available)
 
** Count: 1 patents
 
** Count: 1 patents
−
** Example: [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS simplified abstract (INBIOSE N.V.)]]
+
** Example: [[20240318209. GENETICALLY ENGINEERED BACTERIUM USING GLUCOSE AS SUBSTRATE FOR DE NOVO SYNTHESIS OF VANILLIN AND APPLICATION THEREOF (Beijing University of Chemical Technology)]]
  
 
== Top Companies in Emerging Synthetic Biology Technologies ==
 
== Top Companies in Emerging Synthetic Biology Technologies ==
 
[[File:Top_Companies_in_Emerging_Synthetic_Biology_Technologies.png|border|800px]]
 
[[File:Top_Companies_in_Emerging_Synthetic_Biology_Technologies.png|border|800px]]
  
−
* [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 4 patents
+
* [[:Category:The Regents of the University of California|The Regents of the University of California]]: 3 patents
−
* [[:Category:Eligo Biosciecne|Eligo Biosciecne]]: 3 patents
+
* [[:Category:Taiwan Semiconductor Manufacturing Company, Ltd.|Taiwan Semiconductor Manufacturing Company, Ltd.]]: 3 patents
−
* [[:Category:Wisconsin Alumni Research Foundation|Wisconsin Alumni Research Foundation]]: 3 patents
+
* [[:Category:Regents of the University of Minnesota|Regents of the University of Minnesota]]: 2 patents
 +
* [[:Category:Beijing University of Chemical Technology|Beijing University of Chemical Technology]]: 1 patents
 +
* [[:Category:The Trustees of Columbia University in the City of New York|The Trustees of Columbia University in the City of New York]]: 1 patents
 +
 
 +
== Top Inventors in Synthetic Biology ==
 +
[[File:Top_50_Inventors_in_Synthetic_Biology.png|border|800px]]
 +
 
 +
=== [[:Category:Joeri Beauprez|Joeri Beauprez]] ===
 +
* Number of Synthetic Biology patents: 9
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 9 patents
 +
* Recent patents:
 +
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
 +
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
 +
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
 +
=== [[:Category:Bahram VALAMEHR|Bahram VALAMEHR of San Diego CA (US)]] ===
 +
* Number of Synthetic Biology patents: 6
 +
* Top companies:
 +
** [[:Category:Fate Therapeutics, Inc.|Fate Therapeutics, Inc.]]: 6 patents
 +
* Recent patents:
 +
** [[20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES (Fate Therapeutics, Inc.)]] (20240919)
 +
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
 +
** [[20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS (Fate Therapeutics, Inc.)]] (20240201)
 +
=== [[:Category:David R. Liu|David R. Liu of Cambridge MA (US)]] ===
 +
* Number of Synthetic Biology patents: 5
 +
* Top companies:
 +
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 3 patents
 +
** [[:Category:President and Fellows of Harvard College|President and Fellows of Harvard College]]: 2 patents
 +
* Recent patents:
 +
** [[20240271116. SUPPRESSION OF PAIN BY GENE EDITING (President and Fellows of Harvard College)]] (20240815)
 +
** [[20240209329. PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF (President and Fellows of Harvard College)]] (20240627)
 +
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
 +
=== [[:Category:Pieter Coussement|Pieter Coussement]] ===
 +
* Number of Synthetic Biology patents: 5
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 5 patents
 +
* Recent patents:
 +
** [[20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES (INBIOSE N.V.)]] (20241107)
 +
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
 +
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
 +
=== [[:Category:Thomas Decoene|Thomas Decoene]] ===
 +
* Number of Synthetic Biology patents: 5
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 5 patents
 +
* Recent patents:
 +
** [[20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES (INBIOSE N.V.)]] (20241107)
 +
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
 +
** [[20240191270. FERMENTATIVE PRODUCTION (INBIOSE N.V.)]] (20240613)
 +
=== [[:Category:Annelies Vercauteren|Annelies Vercauteren]] ===
 +
* Number of Synthetic Biology patents: 5
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 5 patents
 +
* Recent patents:
 +
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
 +
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES (INBIOSE N.V.)]] (20240201)
 +
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
 +
=== [[:Category:Ryan BJORDAHL|Ryan BJORDAHL of San Diego CA (US)]] ===
 +
* Number of Synthetic Biology patents: 4
 +
* Top companies:
 +
** [[:Category:Fate Therapeutics, Inc.|Fate Therapeutics, Inc.]]: 4 patents
 +
* Recent patents:
 +
** [[20240115602. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240411)
 +
** [[20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES (Fate Therapeutics, Inc.)]] (20240919)
 +
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
 +
=== [[:Category:Jode GOODRIDGE|Jode GOODRIDGE of San Diego CA (US)]] ===
 +
* Number of Synthetic Biology patents: 4
 +
* Top companies:
 +
** [[:Category:Fate Therapeutics, Inc.|Fate Therapeutics, Inc.]]: 4 patents
 +
* Recent patents:
 +
** [[20240115602. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240411)
 +
** [[20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES (Fate Therapeutics, Inc.)]] (20240919)
 +
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
 +
=== [[:Category:Kristof Vandewalle|Kristof Vandewalle]] ===
 +
* Number of Synthetic Biology patents: 4
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 4 patents
 +
* Recent patents:
 +
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
 +
** [[20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES (INBIOSE N.V.)]] (20240201)
 +
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
 +
=== [[:Category:Tom Tong LEE|Tom Tong LEE of San Diego CA (US)]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:Fate Therapeutics, Inc.|Fate Therapeutics, Inc.]]: 3 patents
 +
* Recent patents:
 +
** [[20240226293. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240711)
 +
** [[20240115602. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240411)
 +
** [[20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF (Fate Therapeutics, Inc.)]] (20240425)
 +
=== [[:Category:Wei Hsi YEH|Wei Hsi YEH of Cambridge MA (US)]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]]: 2 patents
 +
** [[:Category:Prime Medicine, Inc.|Prime Medicine, Inc.]]: 1 patents
 +
* Recent patents:
 +
** [[20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240711)
 +
** [[20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY (Prime Medicine, Inc.)]] (20241024)
 +
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
 +
=== [[:Category:Aaron Nakwon CHANG|Aaron Nakwon CHANG of Lexington MA (US)]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]]: 3 patents
 +
* Recent patents:
 +
** [[20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240711)
 +
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
 +
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
 +
=== [[:Category:Andrew Vito Anzalone|Andrew Vito Anzalone of Cambridge MA (US)]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 3 patents
 +
* Recent patents:
 +
** [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20240711)
 +
** [[20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE (The Broad Institute, Inc.)]] (20240516)
 +
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
 +
=== [[:Category:Roman Lvovitch BOGORAD|Roman Lvovitch BOGORAD of South Boston MA (US)]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 2 patents
 +
** [[:Category:CRISPR THERAPEUTICS AG|CRISPR THERAPEUTICS AG]]: 1 patents
 +
* Recent patents:
 +
** [[20240229078. MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (CRISPR THERAPEUTICS AG)]] (20240711)
 +
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
 +
** [[20240167060. COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES (CRISPR Therapeutics AG)]] (20240523)
 +
=== [[:Category:Dewi HARJANTO|Dewi HARJANTO of Brookline MA (US)]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:Prime Medicine, Inc.|Prime Medicine, Inc.]]: 2 patents
 +
** [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]]: 1 patents
 +
* Recent patents:
 +
** [[20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY (Prime Medicine, Inc.)]] (20241024)
 +
** [[20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS (PRIME MEDICINE, INC.)]] (20240912)
 +
** [[20240376466. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FANCONI ANEMIA (Prime Medicine, Inc.)]] (20241114)
 +
=== [[:Category:Sofie Aesaert|Sofie Aesaert]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 3 patents
 +
* Recent patents:
 +
** [[20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES (INBIOSE N.V.)]] (20241107)
 +
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
 +
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
 +
=== [[:Category:Gert Peters|Gert Peters]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 3 patents
 +
* Recent patents:
 +
** [[20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES (INBIOSE N.V.)]] (20241107)
 +
** [[20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL (INBIOSE N.V.)]] (20240627)
 +
** [[20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES (INBIOSE N.V.)]] (20241003)
 +
=== [[:Category:Jin-Soo Kim|Jin-Soo Kim]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:TOOLGEN INCORPORATED|TOOLGEN INCORPORATED]]: 3 patents
 +
* Recent patents:
 +
** [[20240052356. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240215)
 +
** [[20240240192. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240718)
 +
** [[20240026367. Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240125)
 +
=== [[:Category:Seung Woo Cho|Seung Woo Cho]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:TOOLGEN INCORPORATED|TOOLGEN INCORPORATED]]: 3 patents
 +
* Recent patents:
 +
** [[20240052356. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240215)
 +
** [[20240240192. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240718)
 +
** [[20240026367. Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240125)
 +
=== [[:Category:Sojung Kim|Sojung Kim]] ===
 +
* Number of Synthetic Biology patents: 3
 +
* Top companies:
 +
** [[:Category:TOOLGEN INCORPORATED|TOOLGEN INCORPORATED]]: 3 patents
 +
* Recent patents:
 +
** [[20240052356. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240215)
 +
** [[20240240192. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240718)
 +
** [[20240026367. Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells (TOOLGEN INCORPORATED)]] (20240125)
 +
=== [[:Category:Krishanu Saha|Krishanu Saha of Madison WI (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:Wisconsin Alumni Research Foundation|Wisconsin Alumni Research Foundation]]: 2 patents
 +
* Recent patents:
 +
** [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240711)
 +
** [[20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240425)
 +
=== [[:Category:Lauren Sarko|Lauren Sarko of Middleton WI (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:Wisconsin Alumni Research Foundation|Wisconsin Alumni Research Foundation]]: 2 patents
 +
* Recent patents:
 +
** [[20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240711)
 +
** [[20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING (Wisconsin Alumni Research Foundation)]] (20240425)
 +
=== [[:Category:Ante Sven Lundberg|Ante Sven Lundberg of Cambridge MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:Vertex Pharmaceuticals Incorporated|Vertex Pharmaceuticals Incorporated]]: 1 patents
 +
** [[:Category:Vertex Phamaceuticals Incorporated|Vertex Phamaceuticals Incorporated]]: 1 patents
 +
* Recent patents:
 +
** [[20240226339. Materials and Methods for Treatment of Hemoglobinopathies (Vertex Pharmaceuticals Incorporated)]] (20240711)
 +
** [[20240066150. MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS (Vertex Phamaceuticals Incorporated)]] (20240229)
 +
=== [[:Category:Chase Lawrence Beisel|Chase Lawrence Beisel of Raleigh NC (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:North Carolina State University|North Carolina State University]]: 2 patents
 +
* Recent patents:
 +
** [[20240229012. SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY (North Carolina State University)]] (20240711)
 +
** [[20240132873. SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY (North Carolina State University)]] (20240425)
 +
=== [[:Category:Scott Patrick Collins|Scott Patrick Collins of Raleigh NC (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:North Carolina State University|North Carolina State University]]: 2 patents
 +
* Recent patents:
 +
** [[20240229012. SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY (North Carolina State University)]] (20240711)
 +
** [[20240132873. SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY (North Carolina State University)]] (20240425)
 +
=== [[:Category:David Baram|David Baram]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
 +
* Recent patents:
 +
** [[20240229024. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]] (20240711)
 +
** [[20240132884. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]] (20240425)
 +
=== [[:Category:Lior Izhar|Lior Izhar]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
 +
* Recent patents:
 +
** [[20240229024. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]] (20240711)
 +
** [[20240132884. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]] (20240425)
 +
=== [[:Category:Rafi Emmanuel|Rafi Emmanuel]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:EmendoBio Inc.|EmendoBio Inc.]]: 2 patents
 +
* Recent patents:
 +
** [[20240229024. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]] (20240711)
 +
** [[20240132884. COMPOSITIONS FOR GENOME EDITING (EmendoBio Inc.)]] (20240425)
 +
=== [[:Category:Jonathan M. LEVY|Jonathan M. LEVY of Brookline MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:PRIME MEDICINE, INC.|PRIME MEDICINE, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240711)
 +
** [[20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE (PRIME MEDICINE, INC.)]] (20240523)
 +
=== [[:Category:Yuan WANG|Yuan WANG]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:BEIJING INSTITUTE OF HEART, LUNG AND BLOOD VESSEL DISEASES|BEIJING INSTITUTE OF HEART, LUNG AND BLOOD VESSEL DISEASES]]: 1 patents
 +
** [[:Category:HUAZHONG AGRICULTURAL UNIVERSITY|HUAZHONG AGRICULTURAL UNIVERSITY]]: 1 patents
 +
* Recent patents:
 +
** [[20240229045. APTAMER FOR SPECIFICALLY RECOGNIZING SOLUBLE ST2 PROTEIN AND APPLICATION OF THE SAME (BEIJING INSTITUTE OF HEART, LUNG AND BLOOD VESSEL DISEASES)]] (20240711)
 +
** [[20240368675. PAM-LESS ENDONUCLEASE AND GENE EDITING SYSTEM MEDIATED BY PAM-LESS ENDONUCLEASE (HUAZHONG AGRICULTURAL UNIVERSITY)]] (20241107)
 +
=== [[:Category:James William Nelson|James William Nelson of Cambridge MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The Broad Institute, Inc.|The Broad Institute, Inc.]]: 2 patents
 +
* Recent patents:
 +
** [[20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20240711)
 +
** [[20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES (The Broad Institute, Inc.)]] (20241003)
 +
=== [[:Category:Chad Albert COWAN|Chad Albert COWAN of South Boston MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:CRISPR THERAPEUTICS AG|CRISPR THERAPEUTICS AG]]: 1 patents
 +
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 1 patents
 +
* Recent patents:
 +
** [[20240229078. MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (CRISPR THERAPEUTICS AG)]] (20240711)
 +
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
 +
=== [[:Category:Ante Sven LUNDBERG|Ante Sven LUNDBERG of South Boston MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:CRISPR THERAPEUTICS AG|CRISPR THERAPEUTICS AG]]: 1 patents
 +
** [[:Category:CRISPR Therapeutics AG|CRISPR Therapeutics AG]]: 1 patents
 +
* Recent patents:
 +
** [[20240229078. MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A (CRISPR THERAPEUTICS AG)]] (20240711)
 +
** [[20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (CRISPR Therapeutics AG)]] (20240530)
 +
=== [[:Category:Rasmus O. Bak|Rasmus O. Bak of Stanford CA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The Board of Trustees of the Leland Stanford Junior University|The Board of Trustees of the Leland Stanford Junior University]]: 2 patents
 +
* Recent patents:
 +
** [[20240124895. NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS (The Board of Trustees of the Leland Stanford Junior University)]] (20240418)
 +
** [[20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction (The Board of Trustees of the Leland Stanford Junior University)]] (20241205)
 +
=== [[:Category:Ayal Hendel|Ayal Hendel of Stanford CA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The Board of Trustees of the Leland Stanford Junior University|The Board of Trustees of the Leland Stanford Junior University]]: 2 patents
 +
* Recent patents:
 +
** [[20240124895. NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS (The Board of Trustees of the Leland Stanford Junior University)]] (20240418)
 +
** [[20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction (The Board of Trustees of the Leland Stanford Junior University)]] (20241205)
 +
=== [[:Category:Matthew H. Porteus|Matthew H. Porteus of Stanford CA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The Board of Trustees of the Leland Stanford Junior University|The Board of Trustees of the Leland Stanford Junior University]]: 2 patents
 +
* Recent patents:
 +
** [[20240124895. NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS (The Board of Trustees of the Leland Stanford Junior University)]] (20240418)
 +
** [[20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction (The Board of Trustees of the Leland Stanford Junior University)]] (20241205)
 +
=== [[:Category:Michael Andreas Kock|Michael Andreas Kock]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INARI AGRICULTURE TECHNOLOGY, INC.|INARI AGRICULTURE TECHNOLOGY, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240905)
 +
** [[20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240111)
 +
=== [[:Category:Michael Lee Nuccio|Michael Lee Nuccio of Salem NH (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INARI AGRICULTURE TECHNOLOGY, INC.|INARI AGRICULTURE TECHNOLOGY, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240905)
 +
** [[20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240111)
 +
=== [[:Category:Frédéric Van Ex|Frédéric Van Ex]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INARI AGRICULTURE TECHNOLOGY, INC.|INARI AGRICULTURE TECHNOLOGY, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240905)
 +
** [[20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240111)
 +
=== [[:Category:Alexandra Elata|Alexandra Elata of Arlington MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INARI AGRICULTURE TECHNOLOGY, INC.|INARI AGRICULTURE TECHNOLOGY, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240905)
 +
** [[20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240111)
 +
=== [[:Category:Daniel Rodriguez Leal|Daniel Rodriguez Leal of Raleigh NC (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INARI AGRICULTURE TECHNOLOGY, INC.|INARI AGRICULTURE TECHNOLOGY, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240905)
 +
** [[20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240111)
 +
=== [[:Category:Joshua L. Price|Joshua L. Price of Cambridge MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INARI AGRICULTURE TECHNOLOGY, INC.|INARI AGRICULTURE TECHNOLOGY, INC.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240905)
 +
** [[20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING (INARI AGRICULTURE TECHNOLOGY, INC.)]] (20240111)
 +
=== [[:Category:Sofie De Maeseneire|Sofie De Maeseneire]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294958. EXTRACELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240905)
 +
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
 +
=== [[:Category:Yatti De Nijs|Yatti De Nijs]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294958. EXTRACELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240905)
 +
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
 +
=== [[:Category:Tom Delmulle|Tom Delmulle]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:INBIOSE N.V.|INBIOSE N.V.]]: 2 patents
 +
* Recent patents:
 +
** [[20240294958. EXTRACELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240905)
 +
** [[20240084347. CELLULAR PRODUCTION OF GLYCOSYLATED PRODUCTS (INBIOSE N.V.)]] (20240314)
 +
=== [[:Category:Yakeel T. Quiroz|Yakeel T. Quiroz of Charlestown MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The General Hospital Corporation|The General Hospital Corporation]]: 2 patents
 +
* Recent patents:
 +
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
 +
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
 +
=== [[:Category:Joseph F. Arboleda-Velasquez|Joseph F. Arboleda-Velasquez of Newton MA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The General Hospital Corporation|The General Hospital Corporation]]: 2 patents
 +
* Recent patents:
 +
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
 +
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
 +
=== [[:Category:Eric Reiman|Eric Reiman of Phoenix AZ (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The General Hospital Corporation|The General Hospital Corporation]]: 2 patents
 +
* Recent patents:
 +
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
 +
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
 +
=== [[:Category:Francisco Lopera|Francisco Lopera]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:The General Hospital Corporation|The General Hospital Corporation]]: 2 patents
 +
* Recent patents:
 +
** [[20240287165. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240829)
 +
** [[20240301044. APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF (The General Hospital Corporation)]] (20240912)
 +
=== [[:Category:Radwanul Hasan SIDDIQUE|Radwanul Hasan SIDDIQUE of Monrovia CA (US)]] ===
 +
* Number of Synthetic Biology patents: 2
 +
* Top companies:
 +
** [[:Category:Samsung Electronics Co., Ltd.|Samsung Electronics Co., Ltd.]]: 2 patents
 +
* Recent patents:
 +
** [[20240350024. POLARIZED PHOTOPLETHYSMOGRAPHY (PPG) BIOSENSORS, ARRAYS AND SYSTEMS (Samsung Electronics Co., Ltd.)]] (20241024)
 +
** [[20240065566. POLARIZED PHOTOPLETHYSMOGRAPHY (PPG) BIOSENSORS, ARRAYS AND SYSTEMS (Samsung Electronics Co., Ltd.)]] (20240229)
 +
 
 +
== Top Collaborations in Synthetic Biology ==
 +
[[File:Top_20_Collaborations_in_Synthetic_Biology.png|border|800px]]
 +
 
 +
== Top US States for Synthetic Biology Inventors ==
 +
[[File:Top_10_US_States_for_Synthetic_Biology_Inventors.png|border|800px]]
 +
 
 +
 
 +
== Top Cities for Synthetic Biology Inventors ==
 +
[[File:Top_20_Cities_for_Synthetic_Biology_Inventors.png|border|800px]]
 +
 
 +
* Cambridge: 81 inventors
 +
* Zwijnaarde: 43 inventors
 +
* San Diego: 37 inventors
 +
* Beijing: 18 inventors
 +
* South Boston: 18 inventors
 +
* Boston: 16 inventors
 +
* Seoul: 16 inventors
 +
* Wuhan: 15 inventors
 +
* Stanford: 14 inventors
 +
* Seattle: 14 inventors
 +
* San Francisco: 13 inventors
 +
* Chicago: 10 inventors
 +
* Irvine: 10 inventors
 +
* Durham: 10 inventors
 +
* Raleigh: 8 inventors
 +
* Brookline: 8 inventors
 +
* Burlington: 8 inventors
 +
* Madison: 7 inventors
 +
* Alameda: 7 inventors
 +
* Boise: 7 inventors
  
 
[[Category:Synthetic Biology]]
 
[[Category:Synthetic Biology]]
 
[[Category:Patent Application Trends by Technology in 2024]]
 
[[Category:Patent Application Trends by Technology in 2024]]

Latest revision as of 06:07, 17 December 2024

Contents

Synthetic Biology Patent Application Filing Activity

Synthetic Biology patent applications in 2024

Synthetic Biology Monthly Patent Applications 2024 - Up to November 2024.png

Top Technology Areas in Synthetic Biology

Top Technology Areas in Synthetic Biology 2024 - Up to November 2024.png

Top CPC Codes

Top Companies in Synthetic Biology

Top Companies in Synthetic Biology.png

INBIOSE N.V.

The General Hospital Corporation

Fate Therapeutics, Inc.

PRIME MEDICINE, INC.

The Broad Institute, Inc.

Massachusetts Institute of Technology

The Board of Trustees of the Leland Stanford Junior University

UNIVERSITY OF MASSACHUSETTS

Wisconsin Alumni Research Foundation

Prime Medicine, Inc.

New Companies in Synthetic Biology (Last Month)

800px

No new companies detected in the last month.

Emerging Technology Areas in Synthetic Biology

Emerging Technology Areas in Synthetic Biology.png

Top Companies in Emerging Synthetic Biology Technologies

Top Companies in Emerging Synthetic Biology Technologies.png

Top Inventors in Synthetic Biology

Top 50 Inventors in Synthetic Biology.png

Joeri Beauprez

Bahram VALAMEHR of San Diego CA (US)

David R. Liu of Cambridge MA (US)

Pieter Coussement

Thomas Decoene

Annelies Vercauteren

Ryan BJORDAHL of San Diego CA (US)

Jode GOODRIDGE of San Diego CA (US)

Kristof Vandewalle

Tom Tong LEE of San Diego CA (US)

Wei Hsi YEH of Cambridge MA (US)

Aaron Nakwon CHANG of Lexington MA (US)

Andrew Vito Anzalone of Cambridge MA (US)

Roman Lvovitch BOGORAD of South Boston MA (US)

Dewi HARJANTO of Brookline MA (US)

Sofie Aesaert

Gert Peters

Jin-Soo Kim

Seung Woo Cho

Sojung Kim

Krishanu Saha of Madison WI (US)

Lauren Sarko of Middleton WI (US)

Ante Sven Lundberg of Cambridge MA (US)

Chase Lawrence Beisel of Raleigh NC (US)

Scott Patrick Collins of Raleigh NC (US)

David Baram

Lior Izhar

Rafi Emmanuel

Jonathan M. LEVY of Brookline MA (US)

Yuan WANG

James William Nelson of Cambridge MA (US)

Chad Albert COWAN of South Boston MA (US)

Ante Sven LUNDBERG of South Boston MA (US)

Rasmus O. Bak of Stanford CA (US)

Ayal Hendel of Stanford CA (US)

Matthew H. Porteus of Stanford CA (US)

Michael Andreas Kock

Michael Lee Nuccio of Salem NH (US)

Frédéric Van Ex

Alexandra Elata of Arlington MA (US)

Daniel Rodriguez Leal of Raleigh NC (US)

Joshua L. Price of Cambridge MA (US)

Sofie De Maeseneire

Yatti De Nijs

Tom Delmulle

Yakeel T. Quiroz of Charlestown MA (US)

Joseph F. Arboleda-Velasquez of Newton MA (US)

Eric Reiman of Phoenix AZ (US)

Francisco Lopera

Radwanul Hasan SIDDIQUE of Monrovia CA (US)

Top Collaborations in Synthetic Biology

Top 20 Collaborations in Synthetic Biology.png

Top US States for Synthetic Biology Inventors

Top 10 US States for Synthetic Biology Inventors.png


Top Cities for Synthetic Biology Inventors

Top 20 Cities for Synthetic Biology Inventors.png

  • Cambridge: 81 inventors
  • Zwijnaarde: 43 inventors
  • San Diego: 37 inventors
  • Beijing: 18 inventors
  • South Boston: 18 inventors
  • Boston: 16 inventors
  • Seoul: 16 inventors
  • Wuhan: 15 inventors
  • Stanford: 14 inventors
  • Seattle: 14 inventors
  • San Francisco: 13 inventors
  • Chicago: 10 inventors
  • Irvine: 10 inventors
  • Durham: 10 inventors
  • Raleigh: 8 inventors
  • Brookline: 8 inventors
  • Burlington: 8 inventors
  • Madison: 7 inventors
  • Alameda: 7 inventors
  • Boise: 7 inventors
Retrieved from "http://wikipatents.org/index.php?title=Synthetic_Biology_Patent_Application_Trends_2024&oldid=265399"